To make this website work, we log user data. By using Shephard's online services, you agree to our Privacy Policy, including cookie policy.

Open menu Search

OMFV shows more signs of life

27th July 2021 - 18:30 GMT | by Wilder Alejandro Sanchez in Washington DC


Not for the first time, the KF41 Lynx IFV is being put forward as a solution for the Optionally Manned Fighting Vehicle programme. (Photo: Rheinmetall)

The Optionally Manned Fighting Vehicle programme is moving forward at a deliberate pace, after five industry teams received Phase 2 digital concept design contracts.

US Army Futures Command (AFC) is once again attempting to make progress with the Optionally Manned Fighting Vehicle (OMFV) programme, with the aim of replacing an ageing fleet of M2 Bradley infantry fighting vehicles (IFVs).

In the latest development, US Army Contracting Command issued contracts on 23 July for five industry teams to develop Phase 2 digital concept designs for OMFV.

The total award value for all five contracts is approximately $299.4 million.

One consortium, called Team Lynx (American Rheinmetall Vehicles, Raytheon Technologies, L3Harris Technologies, Textron Systems and Allison Transmission), is offering a Modular Open Systems Approach (MOSA) solution based

Already have an account? Log in

Want to keep reading this article?

Read this Article

Get access to this article with a Free Basic Account

  • Original curated content, daily across air, land and naval domains
  • 1 free story per week
  • Personalised news alerts
  • Daily and weekly newsletters
Create account

Unlimited Access

Access to all our premium news as a Premium News 365 Member. Corporate subscriptions available.

  • Original curated content, daily across air, land and naval domains
  • 14-day free trial (cancel at any time)
  • Unlimited access to all published premium news
Start your free trial
Wilder Alejandro Sanchez


Wilder Alejandro Sanchez

Wilder Alejandro Sánchez is an analyst who covers defense & security, geopolitical, and trade issues …

Read full bio

Share to